Integra LifeSciences launches proposed $600 million senior secured Term Loan B refinancing
IART•Integra LifeSciences launched a proposed $600 million, seven-year Senior Secured Term Loan B refinancing, subject to market conditions and a broader capital structure refinancing; final size, terms and pricing have not been set.
1. Proposed refinancing
Integra LifeSciences launched a proposed $600 million, seven-year Senior Secured Term Loan B refinancing. Net proceeds are earmarked to refinance certain existing indebtedness, cover related fees, preserve financial flexibility and extend maturities; completion is tied to a broader capital structure refinancing and subject to market conditions.
